Charles-Joël Menkès

Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: A randomized, double-blind, placebo-controlled extension trial

Jonathan D. Adachi, Kenneth G. Saag, P. D. Delmas et al. · Arthritis & Rheumatism · 2001 · 550 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Skeletal Benefits of Alendronate: 7-Year Treatment of Postmenopausal Osteoporotic Women¹

Richard P. Tonino, Pierre J. Meunier, Ronald Emkey et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 337 citations

Medicine, Pharmacotherapy, Bone Augmentation +16

Oral alendronate induces progressive increases in bone mass of the spine, hip, and total body over 3 years in postmenopausal women with osteoporosis

J. P. Devogelaer, H Bröll, R Correa-Rotter et al. · Bone · 1996 · 190 citations

Medicine, Endocrinology, Bone Metabolism +14

OCCURRENCE OF PULMONARY COMPLICATIONS DURING METHOTREXATE THERAPY IN RHEUMATOID ARTHRITIS

P. HILIQUIN, M Renoux, Serge Perrot et al. · Lara D. Veeken · 1996 · 103 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

A randomized, double‐blind study comparing twenty‐four‐week treatment with recombinant interferon‐γ versus placebo in the treatment of rheumatoid arthritis

Eric Veys, Charles-Joël Menkès, Paul Emery · Arthritis & Rheumatism · 1997 · 79 citations

Medicine, Internal Medicine, Pharmacotherapy +16